跳至主要内容
临床试验/NCT05678647
NCT05678647进行中(未招募)不适用

Randomized Open Comparative Trial of Oral Sucrosomial Iron (SiderAl Forte®) and Oral Iron Sulphate (Duroferon®) to Blood Donors.

Uppsala University Hospital1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2023年1月31日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
120
试验地点
1
主要终点
Side effects

研究概览

简要总结

2 different oral iron supplementations after blood donation are compared.

详细描述

Iron depletion is common in regular blood donors. During a blood donation the donor loses 200-250 mg iron. The routine at our donor sites is to give donors 20 tablets of iron sulphate (Duroferon®) 100 mg after blood donation.

In this study we will compare two different iron supplementations given after blood donation. 60 donors are given oral sucrosomial Iron (SiderAl Forte®) and 60 donors are given oral iron sulphate (Duroferon®) after 4 successive blood donation.

The primary purpose of this study is to compare the side effects of sucrosomial Iron and iron sulphate and to investigate if the iron balance can be maintained with sucrosomial iron.

After each blood donation the donors are asked to answer a questionary with questions about side effects and symptoms of Restless legs syndrome/Willis-Ekbom (symptoms associated with iron deficiency).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Blood donors at Uppsala University hospital wo have been donating blood regularly the last two years are eligible to participate in the study.

排除标准

  • Donors who cannot be accepted for blood donation anymore because they do not fulfill the Swedish criteria for blood donation.

研究组 & 干预措施

Oral iron sulphate (Duroferon®)

Active Comparator

Oral iron sulphate (Duroferon®) is given to blood donors after blood donation

干预措施: Iron Sulfate (Drug)

Oral sucrosomial Iron (SiderAl Forte®)

Experimental

Oral sucrosomial Iron (SiderAl Forte®) is given to blood donors after blood donation

干预措施: Sucrosomial Iron (Drug)

结局指标

主要结局

Side effects

时间窗: One year

The side effects are compared. At every visit the donors are asked to answer a questionary with questions about side effects. The amount and severity of the side effects will be compared between the two groups with different iron supplementations.

次要结局

  • Iron balance(One Year)
  • Symptoms(One year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Karin Schneider

MD

Uppsala University Hospital

研究点 (1)

Loading locations...

相似试验